News >

FDA Authorizes Tumor Assay Through New Streamlined Pathway

Jason Harris
Published: Wednesday, Nov 15, 2017

The FDA announced that it has approved the IMPACT tumor profiling assay, while also making it easier for some device manufacturers to bring their products to market.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication